Study finds favorable objective response rates for use of Trastuzumab-Deruxtecan in patients with ERBB2-Mutant NSCLC @MDedgeHemOnc https://t.co/a5p8BWpkXg

Recent chemotherapy drug shortages have negatively impacted patient care @MDedgeHemOnc https://t.co/KiRYKaF222

Addition of #Lenvatinib to standard treatment of esophageal squamous cell carcinoma did not show survival benefit @MDedgeHemOnc https://t.co/64ePVgQg1d

Pola-R-CHP shows improved progression free survival over R-CHOP at 5 years for treatment of #DLBCL @MDedgeHemOnc https://t.co/2EtDXTfGhA

Study found no difference in quality of life and side effects between radiation and proton therapies in #OropharyngealCancer @MDedgeHemOnc https://t.co/rIe3ON74PG

Ropeginterferon may be a potential treatment option for patients with essential thrombocythemia @MDedgeHemOnc https://t.co/1uU05wdF4c

Phase 3 Trial finds that Ivonescimab improves progression free survival for patients with EGFR-mutated non-small cell lung cancer @MDedgeHemOnc https://t.co/jGlkoiE5Hm

Study found improved overall survival with statin use for patients taking apalutamide for #ProstateCancer @MDedgeHemOnc https://t.co/yuJXTvu5Iy

Potential improvements in biochemical disease-free survival with use of focal radiation for #ProstateCancer @MDedgeHemOnc https://t.co/eY6RYl4ihf

Study found that #Itacitinib use prior to immune effector cell therapy resulted in decreased incidence of cytokine release syndrome @MDedgeHemOnc https://t.co/H93x42ZYGK

Association between alcohol use and #PancreaticCancer risk may be higher than previously thought @MDedgeHemOnc https://t.co/PrTiFGbO8k

Study highlights links between #LungCancer and Interstitial Lung Disease @MDedgeHemOnc https://t.co/ezMkHtWa1g

#GallbladderCancer and #Cholangiocarcinoma: Improved outcomes with use of #Camrelizumab as part of triple therapy https://t.co/kGYSVGJMml

Study comparing therapies for right-sided metastatic #ColonCancer @MDedgeHemOnc https://t.co/O4EE5jWa7M

Resistance training may improve lymphedema for patients with #BreastCancer @MDedgeHemOnc https://t.co/2c3oBLiTj1

Potential improvements in complete response rates using Sintilimab with standard treatment regimen for #HodgkinLymphoma @MDedgeHemOnc https://t.co/HHtND0HxUp

Improving Outcomes➡️Addition of #Niraparib for metastatic, hormone-sensitive prostate cancer with HRR gene alterations may slow progression @MDedgeHemOnc #ProstateCancer https://t.co/eUkzIFuP96

Impact of Breast Cancer Treatment on Musicality @MDedgeHemOnc #BreastCancer #Musicians https://t.co/8Cyu0HZ2dD

#Prevention of obesity-related cancers using #GLP-1s @MDedgeHemOnc https://t.co/6J3llGrNcy

Suggestions For Discussing Alcohol Use With Patients @MDedgeHemOnc #LifestyleChanges https://t.co/oLrEyTi9z2